Welcome to your Weekly Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Welldoc Cements AI Leadership with Dedicated AI Lab and 100+ Clinical Publications
Welldoc, a leader in AI-powered cardiometabolic health solutions, announced the formal launch of the Welldoc AI Lab and confirmed a significant milestone of over 100 peer-reviewed clinical publications, including 43 dedicated to advanced AI. Together with the company’s 11 FDA clearances and 60 patents, these achievements underscore Welldoc’s unmatched commitment to clinical rigor and evidence-based innovation.
Pluto Health and Help.AI Partner To Improve Surgical Outcomes And Lower Cost Of Care
Pluto Health and Help.AI announced a strategic partnership to advance surgical care by helping teams more effectively understand patients’ needs and close care gaps that commonly delay procedures. The two companies will jointly deploy a next-generation preoperative readiness offering, Valume, to support clinicians and patients through surgical evaluations, reducing delays in care and lowering costs for hospital systems, payers, and patients.
TandemAI Raises $22 Million to Advance AI Drug Discovery
TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced AI, physics-based computational methods, and wet lab capabilities. The round included both new and existing investors. Since its founding in October 2021, the company has raised over $80M.
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
Revvity, Inc. announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end markets. This acquisition expands the breadth and depth of Revvity Signals’ solutions for bridging the gap between analytical data and actionable insights, further strengthening its ability to accelerate scientific innovation. The transaction is expected to close late in Q4 2025.
Talkspace Launches Chapters to Support Women’s Mental Health
Talkspace, a leading online behavioral health company, has introduced Chapters, a new program designed to meet the mental health needs of women at every stage of life. Chapters provides personalized care pathways tailored to each individual, addressing key life transitions from adolescence and young adulthood to family planning, pregnancy, postpartum, midlife, menopause, and caregiving in later years. The program aims to close longstanding gaps in mental health care by offering targeted support for challenges unique to women’s experiences.
RadNet Acquires CIMAR UK to Boost AI Imaging and Screening
RadNet, Inc., a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced the acquisition of CIMAR UK, a leading provider of cloud-native healthcare image management solutions. CIMAR will be integrated into DeepHealth, RadNet’s wholly owned subsidiary and a global leader in AI-powered health informatics, to advance connected imaging-based care.
enGene Reports 62% Complete Response for Detalimogene
enGene Holdings Inc. a clinical-stage, non-viral genetic medicines company, reported additional preliminary data from the pivotal cohort of its ongoing, Phase 2 LEGEND trial of detalimogene voraplasmid (also known as detalimogene and previously EG-70) in high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients with carcinoma in situ (CIS) with or without concomitant papillary disease. Detalimogene’s preliminary data to date and differentiated profile continue to support the Company’s planned Biologics License Application (BLA) submission in the second half of 2026.
Shields Health and Lakeland Regional Partner on Specialty Care
Shields Health Solutions , the premier specialty pharmacy accelerator in the country, has partnered with Lakeland Regional Health, one of Florida’s leading healthcare providers, to improve access to specialty medications for patients managing chronic and complex health conditions.
Olympus Announces New Leadership for Respiratory Division
Olympus Corporation, a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, announced the appointments of Dr. Thomas R. Gildea, MD, MS, FCCP, as Global Lead, Medical Affairs, Respiratory, and Dr. Tamás Ötvös, MD as Global Clinical Lead and Director of Clinical Research, Respiratory, within the Medical & Scientific Affairs (MSA) organization.
To share your insights, please write to us at tony@intentamplify.com
